Financial results - NEURO MEDICINE ROXI S.R.L.

Financial Summary - Neuro Medicine Roxi S.r.l.
Unique identification code: 40923994
Registration number: J2019000570109
Nace: 8622
Sales - Ron
33.978
Net Profit - Ron
28.235
Employees
Open Account
Company Neuro Medicine Roxi S.r.l. with Fiscal Code 40923994 recorded a turnover of 2024 of 33.978, with a net profit of 28.235 and having an average number of employees of - . The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Neuro Medicine Roxi S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 1.555 6.501 14.223 14.744 14.827 33.978
Total Income - EUR - - - - 1.555 6.501 14.223 14.744 14.827 33.978
Total Expenses - EUR - - - - 282 190 340 377 500 492
Gross Profit/Loss - EUR - - - - 1.274 6.311 13.884 14.367 14.327 33.486
Net Profit/Loss - EUR - - - - 1.227 6.116 13.465 13.933 12.079 28.235
Employees - - - - 1 1 1 1 1 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 130.5%, from 14.827 euro in the year 2023, to 33.978 euro in 2024. The Net Profit increased by 16.224 euro, from 12.079 euro in 2023, to 28.235 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Neuro Medicine Roxi S.r.l.

Rating financiar

Financial Rating -
NEURO MEDICINE ROXI S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Neuro Medicine Roxi S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neuro Medicine Roxi S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Neuro Medicine Roxi S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neuro Medicine Roxi S.r.l. - CUI 40923994

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 0 0 0 0 0 0
Current Assets - - - - 1.497 6.266 13.674 14.258 12.945 30.136
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 191 1.226 12.382 9.979 9.685 16.268
Cash - - - - 1.306 5.040 1.292 4.279 3.260 13.867
Shareholders Funds - - - - 1.269 6.166 13.514 13.982 12.127 28.283
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 227 101 160 276 817 1.853
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 30.136 euro in 2024 which includes Inventories of 0 euro, Receivables of 16.268 euro and cash availability of 13.867 euro.
The company's Equity was valued at 28.283 euro, while total Liabilities amounted to 1.853 euro. Equity increased by 16.224 euro, from 12.127 euro in 2023, to 28.283 in 2024.

Risk Reports Prices

Reviews - Neuro Medicine Roxi S.r.l.

Comments - Neuro Medicine Roxi S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.